Prof. Bauza studies various conditions related to cancer diagnostics and treatment, with a particular emphasis on lung nodules and ovarian cancer. He has developed innovative models that help assess risk in patients with suspicious lung nodules, significantly reducing the need for invasive testing. Additionally, he explores how CT imaging can predict the effectiveness of chemotherapy for women with advanced ovarian cancer, enabling quicker adjustments to treatment plans. His research also extends to treating blood disorders, such as neutropenia in patients with Felty's syndrome, which is crucial for infection prevention in immunocompromised patients.
Key findings
His model for assessing patients with lung nodules improved diagnostic accuracy by 12.4%, reducing unnecessary procedures from 62.9% to 50.6%.
For advanced ovarian cancer, an increase in tumor blood volume indicated a lower chance of remaining cancer-free after six months.
In a case study, both G-CSF and GM-CSF successfully improved white blood cell counts in a patient with Felty's syndrome.
During diabetic ketoacidosis in children, 62.4% initially presented with low magnesium levels, which decreased to 25% following treatment.
Frequently asked questions
Does Prof. Bauza study lung cancer?
Yes, he researches the diagnosis and management of lung nodules, focusing on distinguishing cancerous from non-cancerous cases.
What treatments has Prof. Bauza researched for ovarian cancer?
He has studied how CT imaging can help assess the effectiveness of chemotherapy treatments in patients with advanced ovarian cancer.
Is Prof. Bauza's work relevant to patients with Felty's syndrome?
Yes, he has researched treatments for neutropenia related to Felty's syndrome, which is crucial for patients with compromised immune systems.
How does Prof. Bauza's research help children with diabetes?
His work highlights the importance of monitoring and correcting magnesium levels during diabetic ketoacidosis in children.
Publications in plain English
Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules.
2021
American journal of respiratory and critical care medicine
Kammer MN, Lakhani DA, Balar AB, Antic SL, Kussrow AK +34 more
Plain English This study looked at a new way to assess patients with suspicious lung nodules that might be cancerous, which often leads to invasive and expensive tests. Researchers developed a model that combines medical history, blood test results, and imaging to help classify patients' risk levels, which improved diagnostic accuracy by 12.4%. Using this new method could cut down on unnecessary procedures from 62.9% to 50.6% and shorten the time to diagnose cancer from 60 days to just 21 days.
Who this helps: This research benefits patients with lung nodules, allowing for faster and less invasive diagnosis.
CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study.
2017
Clinical cancer research : an official journal of the American Association for Cancer Research
Ng CS, Zhang Z, Lee SI, Marques HS, Burgers K +12 more
Plain English This study looked at how CT perfusion (CTP) measurements might predict how well treatment works for women with advanced ovarian cancer who are receiving chemotherapy. The researchers found that an increase in blood volume in tumors was linked to a lower chance of being free from cancer progression after six months, while an increase in blood flow was tied to a shorter time before the cancer progressed. This information is important because it could help doctors evaluate treatment effectiveness earlier in the course of care.
Who this helps: This helps patients with advanced ovarian cancer by providing doctors with insights into their treatment's effectiveness.
[G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
2000
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia
del Pozo C, Ortiz de Salazar MI, Torregrosa I, Sánchez L, Albero MD +1 more
Plain English This study looked at a patient with Felty's syndrome, a condition that affects the immune system and causes low white blood cell counts, known as neutropenia. The patient, who was also undergoing hemodialysis for kidney failure, was treated successfully with two medications: granulocyte colony-stimulating factor (G-CSF) and granulocyte macrophage colony-stimulating factor (GM-CSF). Both treatments helped improve the patient's white blood cell count, which is important for fighting infections.
Who this helps: This helps patients with Felty's syndrome and low white blood cell counts, especially those on dialysis.
Reliability of serum magnesium values during diabetic ketoacidosis in children.
1998
Boletin de la Asociacion Medica de Puerto Rico
Bauza J, Ortiz J, Dahan M, Justiniano M, Saenz R +1 more
Plain English This study looked at magnesium levels in children with diabetes who were experiencing diabetic ketoacidosis, which is a serious condition. Researchers found that 62.4% of the children had low magnesium levels when they were first admitted, which dropped to 25% after treatment, and returned to normal levels once their condition improved. These findings highlight that low magnesium is common in diabetic ketoacidosis, emphasizing the importance of monitoring and addressing magnesium levels during treatment.
Who this helps: This research benefits doctors and healthcare providers managing children with diabetes.